Xenon Pharmaceuticals Inc. (XENE)
Pharmaceutical Preparations
Latest Price
$56.28
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
13.29
P/B Ratio
4.23
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| FMR LLC | 9.65M | $582.0M | 9.97% | -1.17M | 2026-06-30 |
| BlackRock, Inc. | 7.52M | $454.0M | 7.77% | +1.88M | 2026-06-30 |
| Avoro Capital Advisors LLC | 5.78M | $348.0M | 5.97% | -- | 2026-06-30 |
| Polar Capital Holdings Plc | 4.57M | $275.0M | 4.72% | +165.2K | 2026-06-30 |
| Driehaus Capital Management LLC | 4.42M | $266.0M | 4.57% | -73.1K | 2026-06-30 |
| Jupiter Topco LLC | 4.19M | $252.0M | 4.33% | -- | 2026-06-30 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3.25M | $196.0M | 3.36% | +1.92M | 2026-06-30 |
| JPMORGAN CHASE & CO | 2.62M | $157.0M | 2.71% | +1.12M | 2026-06-30 |
| Capital International Investors | 2.36M | $142.0M | 2.44% | -313.1K | 2026-06-30 |
| T. Rowe Price Investment Management, Inc. | 2.17M | $130.0M | 2.24% | +1.22M | 2026-06-30 |